NA
YCBD icon

NewEdge Advisors’s cbdMD YCBD Stock Holding History

NewEdge Advisors’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$1 – 4175
2025
Q1 		$1 Hold
1
– – ﹤0.01% 3950
2024
Q4 		$2 Hold
1
– – ﹤0.01% 3894
2024
Q3 		$2 Hold
1
– – ﹤0.01% 3797
2024
Q2 		$3 Hold
1
– – ﹤0.01% 3772
2024
Q1 		$5 Hold
1
– – ﹤0.01% 3794
2023
Q4 		$5 Hold
1
– – ﹤0.01% 3726
2023
Q3 		$5 Hold
1
– – ﹤0.01% 3445
2023
Q2 		$7 Hold
1
– – ﹤0.01% 3468
2023
Q1 		$39 Hold
1
– – ﹤0.01% 3369
2022
Q4 		$1 Buy
+1
New +$101 ﹤0.01% 4051

Other funds holding YCBD

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NewEdge Advisors's YCBD Position: Q2 2025 in Review

NewEdge Advisors sold out of cbdMD (YCBD) in Q2 2025, closing a stake of 1 share — an estimated $1 sold.

NewEdge Advisors first reported a position in YCBD in Q4 2022 and held it in 10 quarters. The position peaked at $39 in Q1 2023. 19 funds tracked by Wall St. Rank hold YCBD as of Q2 2025.

  • NewEdge Advisors reported no remaining cbdMD position as of Q2 2025 after selling out during the quarter.
  • NewEdge Advisors sold 1 cbdMD share in Q2 2025, an estimated $1.
  • NewEdge Advisors first reported a position in cbdMD in Q4 2022 and held it in 10 quarters.
  • NewEdge Advisors's cbdMD position peaked at $39 in Q1 2023.
  • 19 funds tracked by Wall St. Rank held cbdMD as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.